Peter
Chovanec
ab,
John F.
Stolz
*b and
Partha
Basu
*a
aDepartment of Chemistry and Biochemistry, Duquesne University, 600 Forbes Ave, Pittsburgh PA 15282, USA. E-mail: basu@duq.edu
bDepartment of Biological Sciences, Duquesne University, 600 Forbes Ave, Pittsburgh PA 15282, USA
First published on 24th December 2009
Clostridial species predominate in both chicken gastrointestinal tract as well as litter where the organoarsenical roxarsone (3-nitro 4-hydroxybenzenearsonic acid) is anaerobically transformed releasing the more recognized toxic inorganic arsenic. 2D-gel electrophoresis and mass spectrometry were used to evaluate the changes in protein expression of Alkaliphilus oremlandii in response to different growth conditions (e.g., terminal electron acceptors) in order to explore the mechanism of microbial biotransformation of roxarsone. Aldehyde ferredoxin oxidoreductase, the enzyme that belongs to the xanthine oxidase family of molybdoenzymes was significantly overexpressed in the presence of roxarsone suggesting a role in the anaerobic metabolism of this substituted nitrophenol.
Organoarsenicals are thought to be stable and not degrade in the environment; however, it is now known that roxarsone can be degraded to inorganic arsenic due to microbial activity8,9 potentially posing an environmental concern.10 We have demonstrated11,12 that roxarsone can be converted to inorganic arsenic by anaerobic bacteria when grown with lactate as an electron donor. The measurable end products were acetate, 3-amino-4-hydroxy-benzenearsonic acid (3A4HBAA), and arsenate, all of which have been quantitated for mass balance. The products are the same whether the roxarsone is degraded by microbes present in the chicken litter or in a pure culture of Alkaliphilus oremlandii. The overall process that consumes lactate producing acetate is shown in eqn (1).
2 roxarsone + 3 lactate →2 3 A4HBAA + 3 acetate + 3 CO2 + H2O | (1) |
![]() | ||
Fig. 1 Representative 2D gels (12.5% acrylamide, 3–11 pH range) of protein fractions from cells of A. oremlandii grown on lactate only (A) and lactate with roxarsone (B). The protein spots that were excised, in-gel digested with trypsin, and analyzed by MALDI-TOF-MS are shown in (C). The numbers correspond to the list of proteins in Table 1. The inset is a higher magnification of the spots identified as AOR. |
Spota | Accession Nob | Locusc | Protein named | MWe | pIf | Coverageg |
---|---|---|---|---|---|---|
a Spot numbers corresponding to those shown in Fig. 1. b Accession number from the NCBI genome sequence database for the gene corresponding to the A. oremlandii. c Locus tag number of the protein. d The protein annotation. e The predicted molecular mass of the identified protein. f The predicted pI of the identified protein. g MS sequence coverage. | ||||||
8 | gi|158319289 | Clos_0237 | Pyruvate flavodoxin/ferredoxin oxidoreductase domain protein | 129350 | 5.39 | 49 |
9 | gi|158321165 | Clos_2140 | Aldehyde ferredoxin oxidoreductase | 78249 | 5.58 | 65 |
13 | gi|158320131 | Clos_1096 | Molybdopterin oxidoreductase | 96667 | 6.32 | 63 |
14 | gi|158319915 | Clos_0879 | Aldehyde oxidase and xanthine dehydrogenasemolybdopterin binding | 86888 | 6.22 | 32 |
15 | gi|158321168 | Clos_2143 | Aldehyde ferredoxin oxidoreductase | 77646 | 6.1 | 61 |
25 | gi|158320201 | Clos_1166 | Oligoendopeptidase F | 70655 | 5.72 | 40 |
39 | gi|158320977 | Clos_1950 | Flavodoxin/nitric oxide synthase | 44692 | 5.3 | 70 |
65 | gi|158321150 | Clos_2125 | 2-oxoglutarate ferredoxin oxidoreductase beta subunit | 31697 | 5.88 | 75 |
67 | gi|158320077 | Clos_1041 | Pyruvate ferredoxin/flavodoxin oxidoreductase | 21142 | 5.27 | 86 |
74 | gi|158321353 | Clos_2331 | Rubrerythrin | 22901 | 5.63 | 81 |
80 | gi|158321166 | Clos_2141 | 4Fe-4S ferredoxiniron-sulfur binding domain protein | 25858 | 7.35 | 49 |
81 | gi|158321169 | Clos_2144 | FeS Protein | 25577 | 8.29 | 56 |
87 | gi|158319291 | Clos_0239 | Desulfoferrodoxin ferrous iron-binding region | 13771 | 5.87 | 95 |
1 | gi|158321647 | Clos_2627 | S-layer domain protein | 101935 | 4.79 | 55 |
2 | gi|158319535 | Clos_0484 | DNA-directed RNA polymerase, beta subunit | 139338 | 4.8 | 26 |
3 | gi|158321644 | Clos_2624 | S-layer protein | 82536 | 4.9 | 63 |
4 | gi|158320998 | Clos_1971 | Phenylalanyl-tRNA synthetase, beta subunit | 89397 | 5.11 | 52 |
5 | gi|158319540 | Clos_0489 | Translation elongation factor G | 76607 | 5.07 | 81 |
6 | gi|158320724 | Clos_1695 | Cobalamin B12-binding domain protein | 82413 | 5.18 | 44 |
7 | gi|158320991 | Clos_1964 | S-layer domain protein | 86229 | 5.28 | 28 |
10 | gi|158321286 | Clos_2264 | Ig -like, group 2 | 102488 | 5.84 | 53 |
12 | gi|158321863 | Clos_2845 | Peptidoglycan-binding domain 1 protein | 79856 | 8.07 | 42 |
16 | gi|158321646 | Clos_2626 | Hypothetical protein Clos_2626 | 73325 | 4.83 | 58 |
17 | gi|158321468 | Clos_2447 | Chaperonin GroEL | 57624 | 4.76 | 63 |
19 | gi|158319637 | Clos_0586 | Pyruvate kinase | 62886 | 5.06 | 70 |
20 | gi|158320738 | Clos_1709 | Aspartyl-tRNA synthetase | 67435 | 5.16 | 59 |
21 | gi|158321621 | Clos_2601 | S-layer domain protein | 69204 | 5.2 | 34 |
22 | gi|158320145 | Clos_1110 | Arsenite-activated ATPase ArsA | 64704 | 5.24 | 64 |
23 | gi|158319487 | Clos_0436 | Methylmalonyl-CoA mutase, large subunit | 62272 | 5.26 | 52 |
24 | gi|158321392 | Clos_2371 | RNA-metabolising metallo-beta-lactamase | 62384 | 5.53 | 30 |
26 | gi|158319518 | Clos_0467 | Glutamyl-tRNA synthetase | 56814 | 5.23 | 52 |
27 | gi|158319995 | Clos_0959 | Sarcosine reductase | 55790 | 5.52 | 64 |
28 | gi|158321152 | Clos_2127 | Formate–tetrahydrofolate ligase | 60122 | 5.76 | 50 |
29 | gi|158319446 | Clos_0395 | Acetyl-CoA carboxylase, biotin carboxylase | 51256 | 5.88 | 72 |
30 | gi|158319584 | Clos_0533 | Inosine-5′-monophosphate dehydrogenase | 52507 | 7.16 | 37 |
31 | gi|158320253 | Clos_1218 | DEAD/DEAH box helicase domain protein | 59230 | 8.4 | 66 |
32 | gi|158319889 | Clos_0851 | Aminotransferase class I and II | 48776 | 4.99 | 72 |
33 | gi|158319527 | Clos_0476 | Translation elongation factor Tu | 44098 | 5.22 | 76 |
36 | gi|158320729 | Clos_1700 | Glycine hydroxymethyltransferase | 45439 | 5.9 | 46 |
37 | gi|158320624 | Clos_1592 | Phosphopentomutase | 42818 | 5.03 | 76 |
38 | gi|158321514 | Clos_2493 | FAD-dependent pyridine nucleotide-disulfide oxidoreductase | 47479 | 5.3 | 63 |
40 | gi|158321641 | Clos_2621 | Outer membrane protein-like protein | 45956 | 5.83 | 68 |
41 | gi|158321480 | Clos_2459 | Glu/Leu/Phe/Val dehydrogenase | 45250 | 5.56 | 73 |
42 | gi|158319685 | Clos_0636 | Acyl-CoA dehydrogenase domain protein | 41315 | 6.06 | 79 |
43 | gi|158320699 | Clos_1670 | Cysteine desulfurase | 43625 | 6.07 | 45 |
44 | gi|158320484 | Clos_1451 | Fatty acid/phospholipid synthesis protein PlsX | 36404 | 6.07 | 86 |
45 | gi|158319945 | Clos_0909 | Pyridoxal phosphate-dependent acyltransferase | 43367 | 6.23 | 71 |
46 | gi|158320194 | Clos_1159 | FMN-dependent alpha-hydroxy acid dehydrogenase | 36349 | 6.96 | 81 |
47 | gi|158319997 | Clos_0961 | Basic membrane lipoprotein | 38677 | 4.46 | 59 |
48 | gi|158319379 | Clos_0327 | Hypothetical protein Clos_0327 | 44008 | 4.37 | 52 |
49 | gi|158319078 | Clos_0019 | Lipoyltransferase and lipoate-protein ligase | 38307 | 5.28 | 62 |
51 | gi|158319585 | Clos_0534 | GMP synthase, large subunit | 36058 | 5.36 | 80 |
52 | gi|158319301 | Clos_0249 | Methylenetetrahydrofolate dehydrogenase (NADP(+)) | 31199 | 5.43 | 63 |
54 | gi|158319458 | Clos_0407 | Branched-chain amino acid aminotransferase | 37699 | 5.74 | 39 |
55 | gi|158319760 | Clos_0712 | D-isomer specific 2-hydroxyacid dehydrogenase NAD-binding | 36170 | 5.71 | 51 |
56 | gi|158321288 | Clos_2266 | Transketolase central region | 33448 | 5.94 | 83 |
58 | gi|158320546 | Clos_1514 | Translation elongation factor Ts | 24318 | 5.2 | 67 |
60 | gi|158319309 | Clos_0257 | Short-chain dehydrogenase/reductase SDR | 26077 | 5.27 | 43 |
61 | gi|158319300 | Clos_0248 | Nitroreductase | 30984 | 5.46 | 87 |
66 | gi|158319887 | Clos_0849 | Short-chain dehydrogenase/reductase SDR | 27513 | 5.64 | 60 |
68 | gi|158321147 | Clos_2122 | CBS domain containing protein | 22284 | 5.6 | 52 |
69 | gi|158321130 | Clos_2105 | HAD-superfamily subfamily IB hydrolase | 28373 | 6 | 68 |
70 | gi|158319749 | Clos_0701 | Stress protein | 21929 | 6.08 | 72 |
73 | gi|158319724 | Clos_0675 | Redoxin domain protein | 19047 | 5.11 | 88 |
75 | gi|158320386 | Clos_1352 | ATP—cobalamin adenosyltransferase | 20342 | 5.64 | 81 |
76 | gi|158319190 | Clos_0134 | Isochorismatase hydrolase | 20665 | 5.79 | 65 |
77 | gi|158320393 | Clos_1360 | Propanediol utilization protein | 20972 | 5.75 | 49 |
78 | gi|158319530 | Clos_0479 | NusG antitermination factor | 19838 | 6.36 | 61 |
83 | gi|158320813 | Clos_1784 | NUDIX hydrolase | 17427 | 5.93 | 97 |
85 | gi|158319578 | Clos_0527 | Ribosomal protein L13 | 16124 | 9.7 | 74 |
Previous studies demonstrated that under the conditions the cells were grown, two major products were detected.11 Nearly 66% of the roxarsone was converted to 3-amino-4-hydroxy-benzenearsonic acid (3A4HBAA) through reduction of the nitro-group. The remaining roxarsone was converted to arsenate, which resulted from either direct ring cleavage or complete conversion of the aromatic ring into a C1 compound. We hypothesized the latter mechanism may be operating.11 At the same time lactate is consumed and acetate is produced.
In principle, roxarsone can accept reducing equivalents that are generated during fermentation (with ATP generated by substrate level phosphorylation of acetyl-CoA), or a terminal electron acceptor linked to oxidative phosphorylation. The genome of A. oremlandii contains genes that encode for proteins required for both the fermentation of lactate and glycolysis. Consistent with this, pyruvate kinase that is involved in the final step in glycolysis in the conversion of phosphoenolpyruvate to pyruvate, with concomitant phosphorylation of ADP to ATP, was identified by MALDI-TOF MS (Table 1). In the acrylate pathway, that generates acetate, enzymes such as lactate dehydrogenase, pyruvate-ferredoxin oxidoreductase, phosphotransacetylase, acetate kinase are involved. Many of these enzymes are found to be present in the genome , but of these, only pyruvate flavodoxin/ferredoxin oxidoreductase (Clos_0237, gi|158319289) has been detected in the roxarsone grown cells. Thus, acrylate pathway may be operative regardless whether roxarsone is present or not in the growth media.
The reduction of nitrophenols can proceed under aerobic as well as anaerobic conditions and can be carried out by a range of organisms17 either by oxidation or by reduction in the presence of an exogenous carbon source to aminoaromatics. The reduction of nitro groups on aromatic compounds by Clostridia is well known.18 For example, C. celerescence is capable of using hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) as a nitrogen source.19 Furthermore, the reduction of the nitro group has been shown to be dependent on the availability of reducing equivalents.20 Genomic analysis of A. oremlandii revealed the presence of two homologues of pentaerythritol tetranitrate reductase (NemA), several nitroreductases, carbon monoxide dehydrogenase, and hydrogenase, all of which have been implicated in the reduction of nitro groups on aromatic compounds. Thus, the reduction of the nitrogroup in roxarsone, in principle, can be carried out by any of these enzymes where the reducing equivalents could be generated from the fermentation of lactate. We have identified five nitroreductases in the genome of A. oremlandii. The five homologues differ in amino acid sequence, molecular mass, and pI and with varying operon structures. Indeed sequence alignment of the nitroreductases shown in Fig. 2 indicates very little homology. Of those, we have detected the largest one (Clos_0248, gi|158319300) indicating that at least this protein is expressed. Future functional assays will reveal whether this protein can reduce the nitro group in roxarsone. From the analysis of the gel images, it appears that this nitroreductase is present in both conditions, thus being expressed constitutively.
![]() | ||
Fig. 2 Sequence alignment by Clustal 2.0.11 of five homologues of nitroreductase. Identified homologue Clos_0248, gi|158319300, in bold red are the peptide fragments identified by MALDI-TOF (79% coverage). |
We hypothesized that the release of inorganic arsenic from roxarsone follows complete degradation of the aromatic ring. Aerobic degradation of nitroaromatics that serve as a source of carbon and nitrogen are known to proceed through complete conversion to inorganic species. Often these reactions are carried out by monooxygenases or dioxygenases. For example, monooxygenase from Pseudomonas sp., has been demonstrated to convert 4-nitrophenol to hydroquinone, with the release of nitrite at the expense of two moles of NADPH per mole of 4-nitrophenol.21 The hydroquinone formed served as a substrate for ring fission forming γ-hydroxy muconic semialdehyde, which is further oxidized to maleyl acetic acid and then to β-ketoadipic acid.21 Alternatively the degradation can proceed viahydroxylation of the ring followed by ring fission to maleyl acetic acid and finally to β-ketoadipic acid.22 Both processes proceed aerobically and suggest an alternative pathway may be operative in the present case. Boll and others have proposed that the anaerobic degradation of the benzene ring proceeds via a benzyl CoA reductase pathway where the CoA activates the ring followed by reduction of the ring, which is subsequently degraded to CO2.23–26 Interestingly, aldehyde ferredoxin oxidoreductase (AOR), a pterin containing molybdoprotein, was found to be expressed at a higher level in cells grown in roxarsone (see Fig. 1, inset). The genome of A. oremlandii contains two homologues of AOR and both copies are found to be expressed at higher level, but to different extents, in roxarsone grown cells. AOR is a hydroxylase that belongs to the xanthine oxidase family of molybdenum enzymes that can hydroxylate an organic substrate. This enzyme is in the same family as benzoyl CoA reductase. Based on the 2-DE data it is provocative to hypothesize that AOR may be involved in the degradation of roxarsone. Whether roxarsone can function as a direct substrate to AOR or its degradation product serves as a substrate remains to be examined. The identification of the AOR is not limited to only one particular spot in the gel , rather peptide sequences obtained from the mass spectral data from several spots matches with the AOR. These spots do not differ in molecular mass but rather differ in their pI. Thus, we suggest that post translational modification of AOR may be taking place (Fig. 3). In addition, genomic data revealed the presence of two different homologues of AOR (Clos_2140, gi|158321165, and Clos_2143, gi|158321168) and both were detected by mass spectral analysis. From the 2-DE, it appears that one of them (Clos_2140, gi|158321165) is expressed more than the other. Thus, both enzymes are expressed under similar regulatory conditions. Unlike the AOR from thermophilic organisms such as Pyrococcus furiosus which harbors W-containing AOR,27AOR from A. oremlandii is associated with an iron sulfur cluster protein. Both copies of the AOR have this iron-sulfur clusterprotein and they (Clos_2141, gi|158321166, and Clos_2144, gi|158321169) have been detected by mass spectrometry. Thus, the AOR from A. oremlandii is compositionally different from that of the P. furiosus.
![]() | ||
Fig. 3 Separation of aldehyde ferredoxine oxidoreductase (1) and pyruvate flavodoxin/ferredoxin oxidoreductase (2) employing a pH range 4–7 strip. The beating pattern is indicative post-translational modifications. These two proteins correspond to spot numbers 9 and 8, respectively in Fig. 1. |
Another important question is whether roxarsone induces the arsenic resistance and respiratory genes. The resistance (ars) and respiratory (arr) operons are part of a large gene cluster and are separated by molybdenum cofactor biosynthetic genes. Recently, we have described the respiratory arsenate reductase functions as a bidirectional enzyme in certain bacteria including A. oremlandii.16 We have identified ArrA, which along with a smaller subunit ArrB make the functional arsenate reductase, in both lactate and roxarsone grown cells. Therefore, we conclude that respiratory arsenate reductaseA. oremlandii is constitutively expressed.
This journal is © The Royal Society of Chemistry 2010 |